Celltrion, Inc. Share Price OTC Markets
Stocks
CONIF
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 42,81500Cr 2.98TCr 2.59TCr 2.41TCr 2.21TCr 4.18TCr 2,84400Cr 4.24TCr 28TCr 11TCr 1,41600Cr 11TCr 11TCr 4,74700Cr | P/E 2026 * |
28.4x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4.48TCr 3.12Cr 2.71Cr 2.52Cr 2.32Cr 4.37Cr 297.49Cr 4.44Cr 30Cr 12Cr 148.1Cr 12Cr 11Cr 496.61Cr | EV / Sales 2026 * |
8.22x | EV / Sales 2027 * | 6.97x |
| Free-Float |
58.02% | Yield 2026 * |
0.41% | Yield 2027 * | 0.44% |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.98TCr | |
| -1.40% | +2.59% | -1.71% | +11.28% | 4.85TCr | |
| -2.41% | -0.90% | +403.17% | +614.40% | 3.99TCr | |
| -1.16% | +12.96% | +26.45% | +5.03% | 3.87TCr | |
| -1.88% | -3.03% | +4.94% | +47.52% | 3.51TCr | |
| -2.85% | -3.92% | - | - | 1.61TCr | |
| -0.21% | -4.04% | +35.09% | +127.95% | 1.61TCr | |
| -0.64% | +2.65% | +1.25% | +8.92% | 1.36TCr | |
| -1.19% | -1.32% | -3.32% | -34.94% | 1.26TCr | |
| -0.90% | +2.62% | +37.06% | +10.96% | 1.12TCr | |
| Average | -1.26% | +0.85% | +62.86% | +98.89% | 2.58TCr | |
| Weighted average by Cap. | -1.37% | +1.75% | +84.09% | +133.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,44900Cr 379.11Cr 329.56Cr 306.75Cr 281.63Cr 531.84Cr 36TCr 540.08Cr 3.62TCr 1.42TCr 18TCr 1.42TCr 1.39TCr 60TCr | 6,32500Cr 440.03Cr 382.52Cr 356.04Cr 326.89Cr 617.3Cr 42TCr 626.86Cr 4.2TCr 1.65TCr 21TCr 1.65TCr 1.62TCr 70TCr |
| Net income | 1,48500Cr 103.33Cr 90Cr 84Cr 77Cr 144.96Cr 9.86TCr 147.21Cr 985.54Cr 386.79Cr 4.91TCr 388.07Cr 379.55Cr 16TCr | 1,76800Cr 123.02Cr 106.94Cr 100Cr 91Cr 172.58Cr 12TCr 175.25Cr 1.17TCr 460.48Cr 5.85TCr 462.01Cr 451.86Cr 20TCr |
| Net Debt | 1,97800Cr 137.59Cr 119.61Cr 111.33Cr 102.21Cr 193.02Cr 13TCr 196.01Cr 1.31TCr 515.03Cr 6.54TCr 516.74Cr 505.39Cr 22TCr | 1,26200Cr 88Cr 76Cr 71Cr 65Cr 123.22Cr 8.38TCr 125.13Cr 837.73Cr 328.78Cr 4.17TCr 329.87Cr 322.63Cr 14TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
